The Bulletin
Times Advertising


.

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

  • Written by PR Newswire
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025.

FY 2025 key results1

Group performance2: Double-digit revenue growth and positive adjusted operating cash flow

  • Revenue of US$803.8 million,...